Skip to main content
. 2021 Sep 6;9(25):7350–7357. doi: 10.12998/wjcc.v9.i25.7350

Table 1.

Comparison of recovery time of various indicators between arbidol therapy group and non–antiviral treatment control group


Arbidol treatment (n = 72)
None-antiviral treatment (n = 60)
P value
Difference (d)
Disease duration (d)1 23.42 ± 6.92 29.60 ± 6.49 < 0.001 6.183
Days before 2 NAT negative results1 21.61 ± 6.95 27.59 ± 6.39 < 0.001 5.983
Days before significantly improved chest CT outcome1 18.33 ± 5.94 24.28 ± 5.35 < 0.001 5.949
1

t test. NAT: Nucleic acid testing; CT: Computed tomography.